Log In
Print this Print this

myRisk Hereditary Cancer Test

  Manage Alerts
Collapse Summary General Information
Company Myriad Genetics Inc.
Description25-gene panel that identifies genetic predisposition to breast, colorectal, ovarian, endometrial, pancreatic, prostate and gastric cancers and melanoma
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsIdentify genetic predisposition in patients with colon cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today